Clinical Trial Update: Short-Term Oral Mifepristone for Central Serous Chorioretinopathy [Phase 2]

View source ↗

Summary

Phase 2 clinical trial of short-term oral mifepristone for Central Serous Chorioretinopathy has completed. The update does not provide trial results within the …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Central Serous Chorioretinopathy

Drugs mentioned

• Mifepristone (mifepristone)

Snippet

Sponsor: Roger Goldberg, M.D., MBA | Conditions: Central Serous Chorioretinopathy | Phase 2 | Status: COMPLETED